Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJETI.L Regulatory News (JETI)

  • There is currently no data for JETI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Conversion of Shares

11 Mar 2020 16:58

RNS Number : 8363F
JPMorgan European Invest Tst PLC
11 March 2020
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

JPMORGAN EUROPEAN INVESTMENT TRUST PLC

CONVERSION OF SHARES

 

Legal Entity Identifier: 549300D8SPJFHBDGXS57

Information disclosed in accordance with LR 9.6.4 (6)

The Board of JPMorgan European Investment Trust plc (the 'Company') announces that valid Conversion Notices have been received in respect of the following Shares (the 'Converting Shares'):

 

- 1,003,249 Growth Shares; and

- 12,664,930 Income Shares.

 

At 8.00 a.m. on 16th March 2020, the above Converting Shares will be converted into:

- 6,518,323 Growth Shares; and

- 1,919,923 Income Shares.

 

(the 'Resulting Shares')

 

Following the conversion, the total number of Shares in issue at 8.00 a.m. on 16th March 2020 will be:

- 74,259,820 Growth Shares; and

- 89,181,557 Income Shares.

 

The conversion calculations were based on the relative net asset values of the two share classes (net of accrued management expenses and applicable costs of conversion) as at close of business on 4th March 2020.

 

The resulting Conversion Ratios were:

- for every Converting Share which is a Growth Share, holders are entitled to 1.913705 Income Shares; and

- for every Converting Share which is an Income Share, holders are entitled to 0.514675 Growth Shares.

 

Individual Shareholders' entitlements on conversion will be rounded down to the nearest whole number of Shares. The Resulting Shares will rank pari passu with the existing Shares of the relevant class of Resulting Share. The Nominal Value of the shares following the conversion will be Growth Shares 3.90508 pence and Income Shares 2.04059 pence.

 

The Resulting Shares have been allotted subject only to admission to the Official List and to trading on the London Stock Exchange's main market for listed securities ('Admission'). The relevant applications have been made and Admission is expected to occur at 8.00 a.m. on 16th March 2020. Dealings in such shares are expected to commence at 8.00 a.m. on 16th March 2020. It is anticipated that Certificates in respect of the Resulting Shares will be posted by 26th March 2020.

 

Terms used in this announcement shall, unless the context otherwise requires, bear the meaning given to them in the Company's articles of association.

 

11th March 2020

For and on behalf of

JPMorgan Funds Limited, Secretary

For further information, please contact: Paul Winship Tel. 020 7742 9815

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCJBMFTMTABBIM
Date   Source Headline
6th Nov 202011:23 amRNSNet Asset Value(s)
5th Nov 202012:18 pmRNSNet Asset Value(s)
4th Nov 202010:40 amRNSNet Asset Value(s)
3rd Nov 202011:27 amRNSNet Asset Value(s)
2nd Nov 202012:05 pmRNSGearing Announcement
2nd Nov 202011:58 amRNSNet Asset Value(s)
30th Oct 202011:42 amRNSNet Asset Value(s)
29th Oct 202011:20 amRNSNet Asset Value(s)
28th Oct 202010:50 amRNSNet Asset Value(s)
27th Oct 202011:09 amRNSNet Asset Value(s)
26th Oct 202012:11 pmRNSGearing Announcement
26th Oct 202011:05 amRNSNet Asset Value(s)
23rd Oct 202010:26 amRNSNet Asset Value(s)
22nd Oct 202012:21 pmRNSNet Asset Value(s)
21st Oct 202011:04 amRNSNet Asset Value(s)
20th Oct 202012:17 pmRNSNet Asset Value(s)
19th Oct 202011:44 amRNSGearing Announcement
19th Oct 202011:00 amRNSNet Asset Value(s)
19th Oct 20209:27 amRNSChange in Investment Management Team
16th Oct 202011:11 amRNSNet Asset Value(s)
15th Oct 202011:17 amRNSNet Asset Value(s)
14th Oct 202010:27 amRNSNet Asset Value(s)
13th Oct 202011:10 amRNSNet Asset Value(s)
12th Oct 20203:34 pmRNSTen Largest Investments
12th Oct 202011:52 amRNSGearing Announcement
12th Oct 202011:10 amRNSNet Asset Value(s)
9th Oct 202011:03 amRNSNet Asset Value(s)
8th Oct 202010:48 amRNSNet Asset Value(s)
7th Oct 202010:51 amRNSNet Asset Value(s)
6th Oct 202011:52 amRNSNet Asset Value(s)
5th Oct 20202:18 pmRNSGearing Announcement
5th Oct 202012:08 pmRNSNet Asset Value(s)
2nd Oct 202011:48 amRNSNet Asset Value(s)
1st Oct 202012:06 pmRNSNet Asset Value(s)
1st Oct 20207:00 amRNSClosed Period
30th Sep 202011:15 amRNSNet Asset Value(s)
29th Sep 202011:37 amRNSNet Asset Value(s)
28th Sep 202012:13 pmRNSGearing Announcement
28th Sep 202011:33 amRNSNet Asset Value(s)
25th Sep 202011:00 amRNSNet Asset Value(s)
24th Sep 202011:15 amRNSNet Asset Value(s)
23rd Sep 202010:59 amRNSNet Asset Value(s)
22nd Sep 202011:31 amRNSNet Asset Value(s)
21st Sep 202011:44 amRNSGearing Announcement
21st Sep 202011:03 amRNSNet Asset Value(s)
18th Sep 202010:49 amRNSNet Asset Value(s)
17th Sep 202010:57 amRNSNet Asset Value(s)
16th Sep 202010:54 amRNSNet Asset Value(s)
15th Sep 202011:11 amRNSNet Asset Value(s)
14th Sep 202012:00 pmRNSGearing Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.